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Summary.-A number of previous studies have shown that the level of natural
killer (NK) cell activity in humans is relatively constant for a given individual but
varies widely between individuals. The factors which determine this variability are
largely unknown, but genetic factors appear to be involved. In the present study it was
found that Rh- normal subjects and melanoma patients had significantly higher
natural cytotoxicity to target cells than Rh+ patients. This difference did not appear
to be due to sensitization against Rh antigens on the target cell and may indicate
that genes determining NK-cell activity are associated with those determining the
expression of Rh antigens.
Analysis of the survival data for Rh- and Rh+ patients did not reveal any increase
in survival attributable to the higher natural cytotoxicity in Rh- patients.
CERTAIN MONONUCLEAR CELLS from the
blood of normal human subjects, referred
to as natural killer (NK) cells, have the
ability to kill a variety of cultured tumour
cells in vitro (Pross & Baines, 1977;
Keissling & Haller, 1978; Hersey, 1979).
The nature of NK cells is still controver-
sial, although many workers agree they
are neither B lymphocytes nor macro-
phages. Recent studies by West et al.
(1977) have supported the notion that
they may be a sub-class of T lymphocytes
(Hersey et al., 1975) but the question is far
from settled.
The mechanism of killing by NK cells
is uncertain, and early evidence suggesting
that it is an antibody-mediated mechan-
ism (Akira & Takasugi, 1977) has not yet
been widely confirmed (Bonnard et al,
1979). Trinchieri & Santoli (1978) have
recently shown that interferon is involved
in the generation of NK-cell activity, and
it is possible that interferon or lympho-
toxin-like factors may be involved in the
cytotoxic mechanism (Bonnard et al.,
1979; Peter et al., 1976).
It is generally accepted that, although
the level of NK-cell activity is constant
for a given person from day to day there
is wide variation in activity between
individuals. The factors underlying this
variation are poorly understood. It has
been shown in mice that the levels ofNK-
cell activity vary between different strains,
and is an inherited characteristic linked
to H2 genes (Kiessling et al., 1975; Keiss-
ling & Haller, 1978). Several studies in
humans also suggest that NK-cell activity
may be under genetic control. Petranyi
et al. (1974) found that mononuclear cells
from HLA A3B7 subjects had low NK-cell
activity to xenogeneic target cells. These
findings were confirmed and extended by
Santoli et al. (1976), who also found male
subjects to have higher NK-cell activity
than females. In the present report we
present evidence, from studies on normal
subjects and melanoma patients, that
inheritance of Rhesus (Rh) antigens may
also be involved in the regulation of NK-
cell activity of human subjects.
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MATERIALS AND METHODS
Normal subjects. Blood samples were
taken from 80 normal subjects (48 male,
32 female) who were volunteer blood donors.
Their ages ranged from 19 to 63 years. Mean
ages were 36 for males and 31 for females.
Forty (20 females, 20 males) were positive
for Rhesus D antigens (Rh+) and 40 (12
females, 28 males) were negative for Rhesus
D antigen (Rh-). Studies on these subjects
were carried out on 4 separate days.
Melanoma patients.-The results of assays
on 95 Rh+ and 18 Rh- male patients and
80 Rh+ and 23 Rh- female patients over the
period 1977-78 were included in the study.
Most of the assays were on patients who had
surgery to remove primary melanoma, with
or without regional lymphnode dissection
(Stage I & II) (73 Rh+ and 13 Rh- males,
59 Rh+ and 16 Rh- females). Some of the
assays were on patients with disseminated
melanoma Stage III, who had palliative
removal of subcutaneous nodules (21 Rh+
and 5 Rh- male patients, 21 Rh+ and 6 Rh-
female patients). Many of the patients were
treated with BCG vaccination with or without
chemotherapy with imidazole carboxamide,
2-4 weeks after removal of their melanoma.
There was no bias towards any particular
form of treatment in Rh+ or Rh- patients.
51Cr-release assay
Assays of NK-cell activity were carried
out essentially as described previously (Her-
sey et al., 1978).
Effector cells were obtained from de-
fibrinated venous blood samples by centri-
fugation on Hypaque: Ficoll mixtures as
described by Boyum (1968). They were
resuspended in RPMI+10% foetal bovine
serum (FBS) at a concentration of 6 x 105/ml.
Target cells were (1) Chang cells from
long-term tissue culture (Commonwealth
Serum Laboratories, Melbourne) and (2)
melanoma cells from the MM200 line described
previously (Hersey et al., 1976). The cells
were harvested by incubation in 0 250/0
trypsin for 15 min and labelled with 51Cr
by incubation with 100 ,Ci Na251CrO4 (Amer-
sham, Bucks, U.K.) at 37°C for 2 h. They
were washed twice in 30 ml of Hanks'
balanced salt solution and resuspended at
6 x 103/ml in RPMI+10% FBS.
Target cells (0 5 ml) and effector cells
(0 5 ml) were incubated together in duplicate
10 x 70 mm round-bottomed tubes for 16 h.
They were then harvested by centrifugation
at 400 g for 7 min and 0 5 ml supernatant
withdrawn for counting. The tubes were
counted in a gamma counter and percent
51Cr release calculated by the formula:
0%5ICr release=a+b x 100
Where a ct-background in tube containing
the supernatant only and b=ct-background
in the tube with the cells and remaining
supernatant.
Statistics. The significance of the differ-
ence between the means of the NK-cell
activity values of effector cells from the Rh-
populations were determined by Student's t
test. The difference in the survival rates of
the Rh- and Rh+ patients were determined
by logrank analysis of the data (Peto et al.,
1977).
RESULTS
NK-cell activity value8 of Rh- and Rh+
normal ssubjects
The NK-cell activity values of 40
normal Rh+ and 40 Rh- subjects are shown
against Chang cells and the melanoma
cells from the MM200 cell line in terms of
51Cr release above the baseline of 51Cr
release from target cells alone. (For
Chang MM 200
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FIG^. 1. NK activity ofRh+ and Rh- normal
subjects against MM200 melanoma cells
and cultured Chang "liver" cells. Mean
percent 51Cr release (4-s.d.) for Rh+ sub-
jects against Chang and MM200 were
13U2+5-3 and 12-2±5-4 respectively and
for Rh- subjects 16-5±7-1 and 15-9±8-7.
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Chang cells the baseline 5lCr release in the
4 consecutive experiments was 32, 35,
32 and 34%. For the MM200 target cells
the 51Cr release in these experiments was
24, 38, 40 and 36%. One value of an Rh-
subject against the MM200 was lost due to
technical error.)
A difference in distribution of the NK-
cell values of Rh- and Rh+ subjects were
seen in the histograms (Fig. 1). The
arithmetic means ±s.d. ofNK-cell activity
from Rh- andRh+ subjects against MM200
cells were 15-9±8-7 and 12-2±5-4 respec-
tively (0-01<P<0-0125). The mean NK-
cell values against Chang cells were 16-5±
7-1 and 13-2±5-3 respectively (0 005<
P<0-01). There was no significant sex
difference between NK-cell values within
each group against either target cell.
NK-cell activity values of Rh- and Rh+
melanoma patients
NK assays against MM200 and Chang
cells were conducted on melanoma patients
before, and 2-4 weeks, 2-3 months and
4-6 months after surgical removal of
melanoma. The mean values of 2-4 assays
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FIG. 2. NK activity of Rh+ and Rh-
melanoma patients against MM200 target
cells. Mean percent 51Cr release for Rh+
and Rh- males were 13-3+6 and 16-9+7-6
respectively; for females, 13-8±7 0 and
16-3+6-3.
of NK-cell activity for each patient were
then calculated and are shown as histo-
grams in Fig. 2 for Rh+ and Rh- male
and female patients. The mean % 5ICr
release against the MM200 target cells
for 95 Rh+ males was 13-3±6 (243
estimations) and for the 18 Rh- males
16 9fr7 6 (41 estimations) (0-0125<P<
0 025). Analysis of the NK-cell values
of melanoma patients at any one time
showed statistically significant difference
between Rh+ and Rh- patients. We assume
this is due to the inherent variability of
the assays from day to day which was
largely circumvented in the studies on
normal subjects by carrying out a large
number of assays on each day. Another
source of extra variation in the results
from melanoma patients may have been
the effect of treatment with BCG and
chemotherapy on NK-cell activity. Both
sources of variation could be expected
to obscure some of the influence of Rh
antigens on NK-cell activity noted in the
normal subjects.
Absence of detectable Rh antiyens on
melanoma or Chany cells
It was considered possible that the
higher NK-cell activity of Rh- subjects
may have been due to recognition of Rh
antigens C and D on the target cells. To
examine this possibility the target cells
were tested for the presence of Rh
antigens C and D, using the IgG fraction
of antisera against these antigens in
51Cr-release LDA assays. No Rh antigens
were detected on the Chang or MM200
cells by these methods nor on melanoma
cell from 3 Rh+ patients.
It was also considered that target cells
from Rh+ patients might have antigens
detected by NK cells from Rh- subjects
that were not detectable by serological
means. To examine this possibility, the
NK-cell activity of Rh- subjects was
tested against melanoma target cells from
both Rh+ and Rh- melanoma patients.
The ratios of NK-cell activity against
target cells from Rh- and Rh+ patients
were then compared to the ratios of NK-
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FIG. 3. Cumulative survival of melanoma patients (868 male, 935 female) (a) according to sex and
Rh status. Rh-, ; Rh+, ---; male, 0; female, 0; (b) In female patients, according to parity
and Rh status Rh-, ; Rh+, -- ; parous, 0; non parous, 0. The improved survival of Rh-
(Fig. 3a) is seen to be confined to parous females.
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cell activity of Rh+ normal subjects
against the same target cells. Ten Rh-
and 10 Rh+ subjects were tested against
melanoma cells from 2 Rh+ patients and
2 melanoma cells from Rh- patients. The
ratio of NK-cell activity of Rh- subjects
against target cells from Rh+ and Rh-
patientswasnotsignificantlydifferentfrom
the ratio of NK-cell activity of Rh+
subjects against the same target cells.
These experiments therefore did not sup-
port the idea that the higher NK-cell
activity of Rh- subjects was due to
sensitization against Rh antigens on the
target cells.
Comparison of the survival of Rh- and
Rh+ melanoma patients
To determine whether the observed
differences in NK-cell values between the
Rh- and Rh+ patients may also be reflec-
ted in a difference in survival of the two
groups, the cumulative survival rates of
all patients who attended the melanoma
unit from 1963 to December 1977 (935
females and 868 males) were determined,
as described by Peto et al. (1977). The
results in Fig. 3(a) indicated a continuous
trend for improved survival of Rh-
females, but the reverse was found for
males. Comparison of the cumulative
10-year survival rates of Rh- and Rh+
women gave a x2 value of 1-15 (P<0-3).
The equivalent value for the 10-year
cumulative survival rates of males was
x2-0.89 (P<0 5). Further analysis of the
data for females shown in Fig. 3(b)
indicated that the improved survival of
Rh-females applied onlytoparouswomen.
The x2 value for the comparison of Rh-
and Rh+ parous women was 1X95 (P<
0 20). These latter data are similar to our
previous published data on the effect of
parity on survival from melanoma (Hersey
et al., 1977).
DISCUSSION
The difference in NK-cell activity shown
in these studies between the Rh- andRh+
subjects of ,20%, appeared to apply to
both normal subjects and melanoma
patients. This difference was only detect-
able by comparison of a large number of
subjects, and indicated that Rh antigens
were probably only one of several influ-
ences on the level of NK-cell activity. No
association was found between NK-cell
activity and the ABO blood groups nor
between NK-cell activity and sex. The
latter result was in contrast to that
previously reported by Santoli et al. (1976)
but we are unable to offer an explanation
for this difference.
The values for melanoma patients rep-
resent the average for assays carried out
at different times on patients with local-
ized melanoma before and after surgery
and on patients with disseminated melan-
oma. Patients in both groups received
various forms of chemotherapy and im-
munotherapy with BCG, both ofwhich are
known to influence levels of NK-cell
activity. It is therefore possible that the
difference in NK-cell activity noted be-
tween Rh- and Rh+ melanoma patients
reflects a bias towards a particular form
oftreatment. Analysis ofthe clinical data,
however, revealed no such bias in patient
management. It is also known that NK-
cell activity is decreased in patients with
disseminated tumours (Takasugi et al.,
1977; Pross & Baines, 1976) but again,
analysis ofour data revealed no significant
difference between the proportion of
patients with disseminated melanoma in
the Rh- and Rh+ groups. These considera-
tions of course do not apply to the studies
on normal subjects.
As discussed previously, it has also been
shown that the HLA-A3B7 haplotype
appears to be associated with low NK-cell
activity (Petranyi et al., 1974; Santoli
et al., 1976) and it is possible that inheri-
tance ofthishaplotypemayhaveinfluenced
our results. However, we know of no
evidence that this particular HLA haplo-
type is preferentially associated with one
or other Rh antigens.
The mechanism underlying the influence
of Rh antigens on NK-cell activity is
unknown. We were unable to obtainNK ACTIVITY AND RHESUS ANTIGENS 239
evidence ofRh antigens on the target cells
used in this study, and it therefore appears
unlikely that sensitization ofRh- subjects
to Rh antigens on the target cells would
account for the results.
In mice it was shown that NK-cell
activity was linked to H2 genes, and it was
postulated that NK-cell activity might be
partly controlled by immune-response
genes in this region, analogous to those
known to regulate antibody production
(Kiessling & Haller, 1978). It is therefore
possible that human genes regulating NK-
cell activity may be associated with the
genes coding for Rh antigens. This sugges-
tionreceived some support from the results
of a workshop on HLA and immune
responses reported by Petranyi et al.
(1974). In those studies on 133 normal
subjects, it was found that Rh+ subjects
had high natural antibody levels and high
lymphocyte responsiveness to phyto-
haemagglutinin, which correlated with
low spontaneous lymphocyte cytotoxicity
to xenogeneic target cells. In view of the
recent reports ofthe influence ofinterferon
on NK-cell activity (Trinchieri & Sanatoli,
1978) it may also be possible that genes
coding for Rh antigens may be associated
with genes regulating interferon produc-
tion.
In our analysis of the survival rates of
Rh- and Rh+ patients, we hoped to deter-
mine whether the difference in NK-cell
activity in these two populations affected
their survival rates. This analysis was
prompted by a number of studies in
experimental animals which suggested
that NK-cell activity may be important
in the host's defence against tumours in
vivo (Kiessling & Haller, 1978).
Our results were conflicting, in that
while Rh- females had apparently better
survival rates than Rh+ females, the re-
verse was found for males. These data
therefore do not support a role for NK-cell
activity in protection against established
melanoma via the higher NK-cell activity
for Rh- subjects in both males and
females. There are, however, a number
oflimitations in using these data to deter-
mine whether NK-cell activity has a role
in vivo against melanoma; thus the 20%
difference in NK-cell activity between the
two populations may be too small to be
reflected in gross survival rates. Alterna-
tively, Rh antigens may be associated
with the expression of other immune-
response genes, such as those coding for
antibody production, which may have an
opposing and greater influence on survival
than that of NK-cell activity.
Similar considerations also apply to the
role of NK-cell activity in preventing the
onset of melanoma, in that if NK-cell
activity has a role in surveillance Rh-
subjects would be expected to have a
lower incidence of melanoma than Rh+
subjects. The ratio ofRh- to Rh+ patients
inourserieswas, however, notsignificantly
different from that in the normal popula-
tion. Again, these data do not support a
role for NK-cell activity in preventing the
onset of melanoma, but the objections to
using the data in this way are as discussed
above.
Although our results suggest that Rh
antigens are associated with NK-cell
activity, this is not reflected in the survival
rates of our melanoma patients. The main
importance ofour results is the suggestion
that Rh antigens may be linked to genes
which regulate the activity of these
cytotoxic cells. It is unlikely that the Rh
antigens are directly involved in this
regulation, since they have so far only been
detected on red blood cells, and it seems
more likely therefore that the Rh-
haplotype is associated in some way with
genes regulating NK-cell activity.
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